MoonLake Immunotherapeutics (MLTX)
Pharmaceutical Preparations
Latest Price
$12.20
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
5.79
P/B Ratio
2.11
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BVF INC/IL | 16.00M | $311.0M | 22.04% | -- | 2026-06-30 |
| Deep Track Capital, LP | 7.00M | $136.0M | 9.64% | +590.2K | 2026-06-30 |
| T. Rowe Price Investment Management, Inc. | 4.28M | $83.0M | 5.90% | +4.28M | 2026-06-30 |
| D. E. Shaw & Co., Inc. | 3.37M | $65.0M | 4.64% | +974.8K | 2026-06-30 |
| Cormorant Asset Management, LP | 3.21M | $62.0M | 4.42% | -1.27M | 2026-06-30 |
| Jupiter Topco LLC | 3.09M | $60.0M | 4.25% | -- | 2026-06-30 |
| Logos Global Management LP | 2.67M | $52.0M | 3.68% | +1.18M | 2026-06-30 |
| Weiss Asset Management LP | 2.58M | $50.0M | 3.56% | +873.5K | 2026-06-30 |
| CITADEL ADVISORS LLC | 2.46M | $47.0M | 3.39% | +376.1K | 2026-06-30 |
| TWO SIGMA INVESTMENTS, LP | 1.72M | $33.0M | 2.36% | -- | 2026-06-30 |